logo
Why Some Men Find Orgasms Elusive

Why Some Men Find Orgasms Elusive

New York Times07-03-2025

Most men, as many as 70 percent, say they reach orgasm quicker than they'd like. But there is an inverse problem that can set in with age: lasting too long.
For some men, reaching climax can take 30 minutes or more. Sex that lasts this long can be uncomfortable, painful and distressing for men and their partners.
Delayed orgasm, as the condition is known, is more commonly associated with women — and for good reason, given the persistent orgasm gap in heterosexual relationships. But up to 10 percent of men over the age of 40 struggle with it, too. In extreme cases, some men can never reach climax, a disorder called anorgasmia.
Orgasm disorders are not well studied or understood, and the little research that does exist tends to focus on premature ejaculation, defined as unintentionally reaching orgasm within two minutes according to the American Urological Association.
But sexual health experts increasingly recognize delayed orgasm as a 'huge problem,' said Dr. Rachel Rubin, a urologist and sex medicine specialist in Maryland. While there are no interventions approved by the Food and Drug Administration, there are some treatment options, including off-label medications, sex therapy and stimulating devices, as well as lifestyle and behavior changes.
How orgasms work
Orgasms are basically a massive reflex, kind of like a 'giant sneeze,' Dr. Rubin said. Just one requiring a 'perfect genital-brain connection.'
The process starts with visual, mental or physical sexual stimulation, triggering the brain to release dopamine, which increases excitement. After sufficient stimulation, the brain releases a surge of pleasure-inducing chemicals, like oxytocin, creating the sensation we think of as an orgasm.
For most men, ejaculation occurs at the same time, 'but they are separate processes,' said Dr. Alan Shindel, a urologist based in San Francisco. While orgasm mostly happens in the brain, ejaculation is a series of involuntary muscle contractions.
Complications affecting the genitals, pelvic floor muscles, spinal cord and brain can make orgasms premature, delayed, muted or even painful, Dr. Rubin said. Given the complexity involved, she said, 'it's actually amazing that more things don't go wrong.'
Causes of delayed orgasm in men
Many physical, neurological or psychological conditions can contribute to delayed orgasm. Here are some of the most widespread causes.
The most common triggers of delayed orgasm are medications and other drugs, including alcohol, said Dr. Landon Trost, a urologist based in Utah. The guidelines from the urological association list 45 different drugs associated with delayed orgasm.
The class of antidepressants called selective serotonin reuptake inhibitors is among the most frequent culprits. These drugs increase serotonin, a chemical that inhibits the neural pathways involved in orgasm, thus raising the threshold required to climax. (For this reason, S.S.R.I.'s are a common off-label treatment for men who ejaculate too quickly.)
Opiates, alcohol, antipsychotics and blood pressure medications, like beta blockers, can also make orgasm difficult by dampening the nervous system's response to sexual stimulation.
Many neurological conditions — including multiple sclerosis, Parkinson's disease, strokes and brain injuries — impair the neural pathways between the brain and genitals, which can result in dulled pleasure, delayed orgasm or painful ejaculation.
Diabetes is another big neurological contributor that often leads to nerve damage. 'It's not just toes and fingers' that are affected, Dr. Shindel said. 'The penis is an extremity, too.'
Spinal injuries are another common cause of delayed orgasm, added Dr. Irwin Goldstein, a urologist based in San Diego. These can include something as simple as a slipped disk.
Another common trigger is the pain or discomfort men may be causing to their partners, which often results in delayed or lack of orgasm for both. Roughly 75 percent women experience pain during intercourse at some point in their lives, some of which is caused by vaginal dryness and irritation, symptoms that can greatly increase at the onset of menopause. The condition is easily treatable with options like local vaginal estrogen, Dr. Rubin said, but often goes undiagnosed and undertreated.
It is 'extremely important' for clinicians treating men for delayed orgasm to 'ask about their partners,' Dr. Rubin said. Differences in libido, preferred types of sex acts and performance expectations can also make it difficult for an orgasm to occur.
Mood disorders — like depression, anxiety and stress — are other common contributors to delayed orgasm. In one self-reported survey, 41 percent of men with moderate to severe delayed orgasm said anxiety and stress during sex was a main reason they were unable to reach climax. Depression in particular can blunt the brain's ability to process pleasure, making orgasm difficult or muted.
Treatments for delayed orgasm
Before treatment, men and their doctors should discuss when the problem started, Dr. Trost said. A sudden onset of delayed orgasm may have a clear trigger (new medications, relationship-related stress or sleep disturbances, for example) and can often be easily reversed. Cases brought on more gradually by age-related conditions and chronic illness may be trickier to treat.
Cases of permanent inability to reach orgasm — caused by the lack of certain dopamine receptors or traumatic brain or spinal injuries — are the most difficult to treat. There are no F.D.A.-approved treatments for delayed orgasm, but clinicians do have a few tools at their disposal.
Several dopamine-promoting drugs — like bupropion, buspirone and cabergoline — have helped counter delayed orgasm for men in some small, randomized control trials.
Sex therapy and counseling are always a good idea for any man with a sexual dysfunction, Dr. Shindel said. Therapy should ideally involve partners, he added, since sexual disorders 'are never just one person's problem.'
Sometimes 'a little more stimulation' can help men reach orgasm more easily, Dr. Rubin said. Sex toys, like vibration devices for the genitals, perineum, prostate or anus, can be helpful to heighten stimulation enough to reach orgasm, she said.
These options don't work for everybody though, said Dr. Shindel, who hopes for new treatments soon. Just as Viagra transformed erectile dysfunction, he said, the same could someday happen for delayed orgasm.
'We're still looking for an orgasm pill,' he said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Merck Gets FDA Approval to Expand Use of Its Top-Selling Drug, Keytruda
Merck Gets FDA Approval to Expand Use of Its Top-Selling Drug, Keytruda

Yahoo

time11 hours ago

  • Yahoo

Merck Gets FDA Approval to Expand Use of Its Top-Selling Drug, Keytruda

Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat head and neck cancers. Studies found patients taking Keytruda can reduce the risk of head and neck cancer recurrence, progression, or death by 30% compared to current treatments. Keytruda is Merck's best-selling drug, generating more than $7 billion in revenue in the first (MRK) has received the go-ahead to expand use of its blockbuster cancer drug, Keytruda. The Food and Drug Administration (FDA) has approved Keytruda's use for adults with resectable locally advanced head and neck squamous cell carcinoma whose tumors express the protein PD-L1. The study's overall principal investigator, Dr. Ravindra Uppaluri, said the approval "represents a potentially significant shift in how we manage this disease." Dr. Uppaluri added Keytruda "has been shown to reduce the risk of recurrence, progression, or death by 30%, compared with standard of care adjuvant chemoradiotherapy or radiotherapy alone." Merck noted that it's estimated that in 2025, there will be approximately 72,680 new cases of head and neck cancer diagnosed, and more than 16,680 deaths from the disease. Keytruda is the company's best-selling drug, with first-quarter revenue of $7.2 billion, making up nearly half of its total sales. Entering Friday trading, shares of Merck were down about 18% year-to-date. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Confused over the conflicting COVID vaccine guidance? Here's what to know
Confused over the conflicting COVID vaccine guidance? Here's what to know

San Francisco Chronicle​

timea day ago

  • San Francisco Chronicle​

Confused over the conflicting COVID vaccine guidance? Here's what to know

Federal health officials have in recent weeks given conflicting — and at times confusing — guidance around who should get vaccinated against COVID-19. These changes mark a significant departure from the Centers for Disease Control and Prevention's previous recommendations, which advised everyone 6 months and older to get the vaccine. On May 20, Dr. Marty Makary, commissioner of the Food and Drug Administration, published an article in the New England Journal of Medicine saying the FDA will make the vaccine available only to adults 65 and older and people with at least one underlying medical condition — meaning vaccines will no longer be recommended for healthy adults under 65. On May 27, Health Secretary and longtime vaccine skeptic Robert F. Kennedy Jr. unilaterally announced that the federal government no longer recommends the vaccine for children and pregnant women, and that the vaccine was removed from the immunization schedule recommended by the Centers for Disease Control and Prevention. But days later, the CDC partly contradicted this pronouncement, saying the vaccine will remain on the childhood immunization schedule — but added a new clarification that parents should consult with their children's doctor when deciding whether to get their child immunized. The CDC offered no formal guidance on whether pregnant women should get the vaccine, though its website lists pregnancy as an underlying condition that puts someone at higher risk of severe COVID and thus makes them eligible for vaccination going forward. What should you do? One practical thing to keep in mind, according to some experts, is you may just want to wait and see how things shake out. The next updated COVID vaccine, for 2025-26, won't be rolled out until the fall. And before then, we may get more clarity on who it will be recommended for — and thus whom health insurers will cover it for. Insurers typically pay for vaccines only if they're recommended by the federal government. We may get clarification this month: The Advisory Committee on Immunization Practices, an outside panel of scientific experts that advises the CDC on vaccine recommendations, is scheduled to meet June 25-27 to vote on 2025-26 COVID vaccine recommendations. Historically, this panel has advised the CDC director on vaccine recommendations, and the CDC then communicates its recommendations with the public. Kennedy bypassed this long-held protocol by going ahead and changing vaccine recommendations without input from the CDC's advisory panel. As it stands: Adults 65 and over The recommendation for this group is not changing. Adults 65 and older should get the COVID vaccine every six months. This group can expect to get the same access to vaccination as they've had since the pandemic began, meaning their insurer should continue covering it since the federal government recommends it for them. People 6 months and older with at least one underlying medical condition The vaccinations are also still recommended for those in this age group with one or more underlying conditions putting them at higher risk for severe COVID. Pregnant women The federal government's position on whether pregnant women should get immunized is unclear. While Kennedy said the vaccine for pregnant women was no longer recommended by the CDC, the FDA's Makary said a day later that the decision to vaccinate should be made by the pregnant person and their doctor. Infectious disease experts and obstetricians urge pregnant women to get the vaccine. This is because pregnant people who get COVID are more likely to develop severe disease, need hospitalization and ICU care, and experience pregnancy complications including preeclampsia, miscarriage, preterm birth and higher likelihood of developing blood clots, said Nadia Roan, a UCSF professor and senior investigator at Gladstone Institutes who studies immunology. 'There's a ton of data that's been generated over recent years suggesting that boosting or vaccination during pregnancy is beneficial,' said Roan, who is researching COVID boosters in pregnant people. Also, getting immunized during pregnancy is the only way to pass protection on to the fetus, and have the infant protected in early life. 'If you vaccinate and you're in the third trimester, you're essentially vaccinating your fetus,' said Dr. George Rutherford, a professor emeritus of epidemiology and biostatistics at UCSF. 'That's a good thing because it's not approved for people under 6 months yet. So this is how we get to that population.' If you're pregnant and wondering whether you should get the current 2024-25 vaccine now — in case you can't get the updated 2025-26 vaccine later due to new federal recommendations that have yet to be determined — 'I'd say yes because I'm not sure it'll be covered in the fall,' said Dr. Peter Chin-Hong, an infectious-disease specialist at UCSF. 'It's not harmful, particularly if you haven't had one in the last year,' he said. The vaccine is safe to get at all stages of pregnancy, he said. Healthy adults under 65 For this group, whether to get vaccinated is a little more open to interpretation, experts said, and can factor in things like each person's risk tolerance, job and living situation. 'I'd talk to their health care provider at the end of the day to help guide them more,' Chin-Hong said. 'Everyone has different situations and circumstances.' You may want to lean toward vaccination if, for instance, you plan to travel this summer (when abroad, you don't have access to your usual health care providers) or if you live with immunocompromised or older adults and want to lower the chances of spreading COVID to them. 'In general, (healthy adults) are going to do fine, so to me it's really about protecting the people who are most vulnerable,' Chin-Hong said. Children About 2,000 children in the U.S. have died from COVID since 2020, and more than 200,000 have been hospitalized. Those numbers are much lower compared with people in higher-risk groups, especially those over 65, and most healthy children likely experience mild or moderate symptoms. Still, many infectious diseases experts say the benefits of vaccination do still outweigh the risks — though that calculus is much closer than it is for pregnant people and adults over 65. 'It's a small number compared to deaths in many other age ranges, but that's deaths, many of which could've been prevented if they were vaccinated,' said Dr. John Swartzberg, a clinical professor emeritus of infectious diseases at UC Berkeley School of Public Health. The vaccines have proved safe and effective in children, lower the likelihood of severe disease, and help reduce long COVID risk, Roan said. 'The risks (of vaccination) are very low, and these vaccines have been shown to be safe,' Roan said. 'So I think the benefits definitely outweigh the risks. But it's up to each individual to make that decision.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store